Scientists get closer to blood test for Alzheimer's disease

New study results are boosting hopes that there soon may be a simple, reliable way to help family doctors diagnose the most common form of dementia
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news

Related Links:

This study aimed to evaluate the effect of cognitive training programs on the progression of dementia in patients with early stage Alzheimer's disease dementia (ADD) at the day care center. METHODS: From January 2015 to December 2018, a total of 119 patients with early ADD were evaluated. All subjects were classified into two groups according to participate in cognitive training program in addition to usual standard clinical care. Changes in scores for minimental status examination-dementia screening (MMSE-DS) and clinical dementia rating-sum of boxes (CDR-SOB) during the 12 months were compared between two groups. Mul...
Source: Psychiatry Investigation - Category: Psychiatry Tags: Psychiatry Investig Source Type: research
This article presents the rationale, aims, study design, and organization of TIS. In addition, we described some examples of the types of studies such a resource might support. The TIS provides a new framework for facilitating Chinese dementia research, encompassing invaluable resources including detailed epidemiological, sociocultural, neuroimaging, and omics data. PMID: 32776666 [PubMed - as supplied by publisher]
Source: The Journal of Alzheimers Association - Category: Psychiatry Tags: Alzheimers Dement Source Type: research
Phys. Chem. Chem. Phys., 2020, Accepted Manuscript DOI: 10.1039/D0CP02459G, PaperShivani Gupta, Ashok Kumar Dasmahapatra The clinical signature of Alzheimer ’s disease (AD) is the deposition of aggregated Aβ fibrils that are neurotoxic to the brain. It is the major form of dementia affecting older people... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Phys. Chem. Chem. Phys. latest articles - Category: Chemistry Authors: Source Type: research
Recently, imaging biomarkers have gained importance for the characterization of patients with Alzheimer’s disease; however, the relationship between regional biomarker expression and cognitive function remains unclear. In our study, we investigated associations between scores on CERAD neuropsychological assessment battery (CERAD-NAB) subtests with regional glucose metabolism, cortical thickness and amyloid deposition in patients with early Alzheimer’s disease (AD) using [18F]-fluorodeoxyglucose (FDG), structural MRI, and 11C-Pittsburgh Compound B (PiB) positron emission tomography (PET), respectively. A total o...
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
Dementia Research Chatathon - 7 September, 9:00  (GMT+1)For 12 hours the host Adam Smith (@BetterResearch) will be chatting with  55 researchers from all fields of dementia research, using video chat – live streamed using Zoom and YouTube. They will discus their research, the latest hot topics in their field, and how they are working to beat the disease and improve the lives of people affected. This event is open to everyone interested i n finding out more about the latest research taking place on dementia and information will be accessible to researchers, healthcare professionals, and family and carer...
Source: Cochrane News and Events - Category: Information Technology Authors: Source Type: news
Older individuals who are informed by health care professionals that they have elevated levels of the protein amyloid —a known risk factor for Alzheimer’s disease—do not appear to experience adverse short-term psychological responses compared with those who learn their amyloid levels are normal, according to areport inJAMA Neurology.“We found that trial participants who did not have cognitive impairment and received an elevated amyloid result were no more likely than those receiving a not elevated amyloid result to experience depression, anxiety, or catastrophic reactions in the short term,” w...
Source: Psychiatr News - Category: Psychiatry Tags: Alzheimer's disease amyloid anxiety depression JAMA Neurology suicidality Source Type: research
Conditions:   Alzheimer Disease;   Dementia Interventions:   Drug: 11C-ER176;   Drug: [F-18]MK-6240;   Drug: Florbetaben;   Other: Magnetic Resonance Imaging Sponsor:   Jose Gutierrez Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The personality changes came ahead of more obvious behavioural changes linked to Alzheimer's. → Support PsyBlog for just $5 per month. Enables access to articles marked (M) and removes ads. → Explore PsyBlog's ebooks, all written by Dr Jeremy Dean: Accept Yourself: How to feel a profound sense of warmth and self-compassion The Anxiety Plan: 42 Strategies For Worry, Phobias, OCD and Panic Spark: 17 Steps That Will Boost Your Motivation For Anything Activate: How To Find Joy Again By Changing What You Do
Source: PsyBlog | Psychology Blog - Category: Psychiatry & Psychology Authors: Tags: Dementia Source Type: blogs
Title: What Is the Difference Between Dementia and Alzheimer's?Category: Diseases and ConditionsCreated: 8/12/2020 12:00:00 AMLast Editorial Review: 8/12/2020 12:00:00 AM
Source: MedicineNet Alzheimer - Category: Geriatrics Source Type: news
This study aimed to investigate differences in functional connectivity (FC) among different resting state networks (RSN) in clinically non-progressive mild cognitive impairment (MCI) and Alzheimer's disease (AD).
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Source Type: research
More News: Alzheimer's | Dementia | Health | Study